TO BE THE FIRST MOVER,
WORK WITH ONE
WORK WITH ONE
TO BE THE FIRST MOVER,
WORK WITH ONE
WORK WITH ONE
Accelerating Therapeutic Development Through Patient Discovery
At 3X Genetics, we can accelerate the treatment of genetic diseases through sponsored testing of diagnosed patients and their families. The high precision and low cost of the 3X-TGT platform enables biopharma companies to rapidly discover patients to support clinical trials. We can also use our breakthrough computational biology algorithms to develop custom biomarker assays that can measure the efficacy of proposed or approved therapeutics.
Clinical Trial Support
3X Genetics supports clinical trials by offering CLIA-certified test results, reducing the risks associated with reporting results from non-validated lab work flows. Through our sponsored testing program, we also offer patient discovery services to accelerate recruitment for clinical trials.
Services include:
- Patient recruitment and enrollment support
- Companion diagnostic research, development, and integration
- Methylation and other epigenetic assay support
- Secure IT infrastructure and compliant data transfer
- Quality assurance and compliance support
Custom Assay Development
Using our patent-pending computational biology algorithms, 3X Genetics can rapidly develop custom assays for both structural and functional genomics. Our platform addresses repetitive and complex genomic regions, including repeat expansions, pseudogenes, and other sequences that challenge short-read technologies, as well as dynamic molecular signatures such as methylation status, epigenetic modifications, and RNA expression profiles.
